Literature DB >> 15518189

Characterization of a novel form of X-linked incomplete achromatopsia.

Michael A Crognale1, Michael Fry, Jennifer Highsmith, Gunilla Haegerstrom-Portnoy, Maureen Neitz, Jay Neitz, Michael A Webster.   

Abstract

X-linked incomplete achromatopsia (XIA), also called blue-cone monochromacy (BCM), is a rare cone disorder that most commonly results either from one of two conditions. The first condition is a deletion of the locus control region (LCR) which is a critical DNA element that lies upstream of the L and M photopigment gene array on the X-chromosome and is necessary for expression of the photopigment genes. The second condition is an inactivating point mutation within the coding sequence of the remaining photopigment gene in an array from which all but one gene has been deleted. Many previous studies have concluded that affected individuals either have only rods and S-cones (Blackwell & Blackwell, 1957, 1961; Daw & Enoch, 1973; Hess et al., 1989) or have rods, S-cones, and another cone type that contains the rod pigment (Pokorny et al., 1970; Alpern et al., 1971). However, Smith et al. (1983) described individuals with XIA who had residual L-cone function. Here we report results for a subject with XIA who appears to have residual M-cone function. Genetic analysis revealed that he had apparently normal genes for M-cone photopigment thus leaving open the possibility that he has a contribution to vision based on expression of these genes at a very low level.

Entities:  

Mesh:

Year:  2004        PMID: 15518189     DOI: 10.1017/s0952523804213384

Source DB:  PubMed          Journal:  Vis Neurosci        ISSN: 0952-5238            Impact factor:   3.241


  17 in total

Review 1.  Advances in understanding the molecular basis of the first steps in color vision.

Authors:  Lukas Hofmann; Krzysztof Palczewski
Journal:  Prog Retin Eye Res       Date:  2015-07-15       Impact factor: 21.198

2.  The effect of cone opsin mutations on retinal structure and the integrity of the photoreceptor mosaic.

Authors:  Joseph Carroll; Alfredo Dubra; Jessica C Gardner; Liliana Mizrahi-Meissonnier; Robert F Cooper; Adam M Dubis; Rick Nordgren; Mohamed Genead; Thomas B Connor; Kimberly E Stepien; Dror Sharon; David M Hunt; Eyal Banin; Alison J Hardcastle; Anthony T Moore; David R Williams; Gerald Fishman; Jay Neitz; Maureen Neitz; Michel Michaelides
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-05       Impact factor: 4.799

Review 3.  The genetics of normal and defective color vision.

Authors:  Jay Neitz; Maureen Neitz
Journal:  Vision Res       Date:  2010-12-15       Impact factor: 1.886

4.  Color-deficient cone mosaics associated with Xq28 opsin mutations: a stop codon versus gene deletions.

Authors:  Melissa Wagner-Schuman; Jay Neitz; Jungtae Rha; David R Williams; Maureen Neitz; Joseph Carroll
Journal:  Vision Res       Date:  2010-09-17       Impact factor: 1.886

5.  Variations in opsin coding sequences cause x-linked cone dysfunction syndrome with myopia and dichromacy.

Authors:  Michelle McClements; Wayne I L Davies; Michel Michaelides; Terri Young; Maureen Neitz; Robert E MacLaren; Anthony T Moore; David M Hunt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-15       Impact factor: 4.799

6.  S-opsin knockout mice with the endogenous M-opsin gene replaced by an L-opsin variant.

Authors:  Scott H Greenwald; James A Kuchenbecker; Daniel K Roberson; Maureen Neitz; Jay Neitz
Journal:  Vis Neurosci       Date:  2014-01       Impact factor: 3.241

7.  Rod and rod-driven function in achromatopsia and blue cone monochromatism.

Authors:  Anne Moskowitz; Ronald M Hansen; James D Akula; Susan E Eklund; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

8.  Cone photoreceptor mosaic disruption associated with Cys203Arg mutation in the M-cone opsin.

Authors:  Joseph Carroll; Rigmor C Baraas; Melissa Wagner-Schuman; Jungtae Rha; Cory A Siebe; Christina Sloan; Diane M Tait; Summer Thompson; Jessica I W Morgan; Jay Neitz; David R Williams; David H Foster; Maureen Neitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-23       Impact factor: 11.205

9.  Human cone visual pigment deletions spare sufficient photoreceptors to warrant gene therapy.

Authors:  Artur V Cideciyan; Robert B Hufnagel; Joseph Carroll; Alexander Sumaroka; Xunda Luo; Sharon B Schwartz; Alfredo Dubra; Megan Land; Michel Michaelides; Jessica C Gardner; Alison J Hardcastle; Anthony T Moore; Robert A Sisk; Zubair M Ahmed; Susanne Kohl; Bernd Wissinger; Samuel G Jacobson
Journal:  Hum Gene Ther       Date:  2013-10-30       Impact factor: 5.695

10.  Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.

Authors:  Xunda Luo; Artur V Cideciyan; Alessandro Iannaccone; Alejandro J Roman; Lauren C Ditta; Barbara J Jennings; Svetlana A Yatsenko; Rebecca Sheplock; Alexander Sumaroka; Malgorzata Swider; Sharon B Schwartz; Bernd Wissinger; Susanne Kohl; Samuel G Jacobson
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.